Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome

Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome

Background Psoriasis is a chronic immune-mediated hyperproliferative disease frequently associated with systemic comorbidities including metabolic syndrome (MS). Interleukin-17 (IL-17) has been identified as a central player in psoriasis-associated inflammation. Objective To investigate serum IL-17...

Full description

Bibliographic Details
Main Authors: Hanan Morsy, Ashraf Hasaballa, Sara Awad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of the Egyptian Women’s Dermatologic Society
Subjects:
il-17
metabolic syndrome
psoriasis
Online Access:http://www.jewd.eg.net//article.asp?issn=1687-1537;year=2019;volume=16;issue=3;spage=164;epage=169;aulast=Morsy

Internet

http://www.jewd.eg.net//article.asp?issn=1687-1537;year=2019;volume=16;issue=3;spage=164;epage=169;aulast=Morsy

Similar Items